Contact SRI Biosciences

Center for Infectious Disease and Biodefense Research

Infectious diseases represent a global public health challenge making the discovery of safe and effective therapeutics an imperative. Our Center seeks to better understand infectious disease mechanisms in order to create new diagnostics, prophylactics, and therapeutics. We bring a wealth of experience and diverse scientific interests to our mission of benefitting mankind by creating new opportunities and approaches for defeating the world's most significant infectious disease threats. A number of the diseases we study disproportionately affect the poor living in remote rural areas, urban slums, and places of political conflict and are often a major barrier to escaping extreme poverty. With over 50 years of experience in anti-infective research, we are uniquely positioned to discover and develop new drugs to treat bacterial, viral and parasitic diseases. SRI's research successes in anti-infectives include halofantrine, a drug used to treat malaria, and vidarabine, a drug that blocks the spread of the herpes simplex virus.

Featured Programs

Microbiology	Tropical Diseases	Virology	Vector Biology

Featured Solutions

Cell and Molecular Imaging	Medicinal Chemistry	Screening Services

Publications

Brochures

In the News

Contact SRI Biosciences

       Last Updated May 16, 2012